Pharmaceutical Companies Can Lead the Healthcare Industry into the Age of Digital Consumer Engagement. Friction is the Enemy and the Opportunity.

Digital Conversations

Despite countless billions of dollars spent, and decades of effort, healthcare still lags behind other industries when it comes to successfully using digital technologies to interact with its customers — the patients. The ongoing challenges created by the COVID-19 pandemic have resulted in rapid advances in digital health solutions and telehealth. The pharmaceutical industry essentially performed a miracle in delivering several effective new drugs in just months.

Bradford Lee, VP of Life Sciences at Lifelink Systems, sat down with Greg Kefer to share some of the developments he’s been part of in his role working with top innovation executives across all segments of the pharmaceutical industry. The combination of big organizations, legacy processes, and heavy regulation have historically held back rapid innovation and Silicon Valley thinking, but that may be changing.

Mature technology that's mobile and conversational is lowering the friction barrier for patients and trial participants. Healthcare providers are showcasing their digital transformation successes, paving the path for the entire industry. We are also seeing the traditional internal barriers for digital transformation come down as life science companies begin to look for ways to deploy simple, effective solutions quickly to get wins on the board and begin to generate the kinds of results needed for wide-scale innovation. Healthcare may be on the cusp of finally catching up to the other consumer industries that the leaders keep saying they want to emulate.